O

OrbiMed Portfolio holdings

AUM $3.98B
1-Year Est. Return 13.05%
This Quarter Est. Return
1 Year Est. Return
+13.05%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.91B
AUM Growth
-$1.07B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
169
New
Increased
Reduced
Closed

Top Buys

1
+$139M
2
+$132M
3
+$110M
4
PFE icon
Pfizer
PFE
+$98.3M
5
GILD icon
Gilead Sciences
GILD
+$85.6M

Top Sells

1
+$372M
2
+$99.8M
3
+$98.1M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$93.8M
5
TNDM icon
Tandem Diabetes Care
TNDM
+$68M

Sector Composition

1 Healthcare 97.58%
2 Financials 1.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
101
$5.31M 0.09%
375,800
102
$5.15M 0.09%
1,250,396
103
$4.97M 0.08%
690,055
104
$4.89M 0.08%
+211,545
105
$4.7M 0.08%
179,598
106
$4.69M 0.08%
+24,324
107
$4.54M 0.08%
+80,760
108
$4.08M 0.07%
+1,067,600
109
$3.91M 0.07%
1,464
-1,092
110
$3.77M 0.06%
28,591
-227,709
111
$3.49M 0.06%
135,333
112
$3.24M 0.05%
+801,000
113
$3.22M 0.05%
420,641
+260,100
114
$3.21M 0.05%
262,100
115
$3.18M 0.05%
290,000
+78,000
116
$2.86M 0.05%
346,263
117
$2.79M 0.05%
+179,500
118
$2.67M 0.04%
18,578
119
$2.64M 0.04%
+18,556
120
$2.58M 0.04%
750,000
-250,000
121
$2.51M 0.04%
1,162,108
+1,019,108
122
$2.4M 0.04%
+6,706
123
$2.23M 0.04%
+600
124
$1.96M 0.03%
+68,100
125
$1.35M 0.02%
+50,485
3 4
5
6 7